Effect of CYP3A4*22 and CYP3A5 Combined Genotypes on Tacrolimus Disposition in Heart Transplantation

被引：1
|
作者：
Vu, A. [1 ]
Page, R. L. [2 ]
Roscoe, N. [1 ]
Lindenfeld, J. A. [3 ]
Aquilante, C. L. [1 ]
机构：
[1] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA
[2] Univ Colorado, Dept Clin Pharm, Aurora, CO USA
[3] Univ Colorado, Dept Med, Aurora, CO USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2014年 / 33卷 / 04期
关键词：
D O I：
10.1016/j.healun.2014.01.028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
301
引用
收藏
页码：S115 / S116
页数：2
相关论文
共 50 条
  • [1] Effect of CYP3A4* 22, CYP3A5* 3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, J. J. Homan
    Sanders, J. S.
    Bemelman, F. J.
    de Fijter, J. W.
    Guchelaar, H. J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (02):
  • [2] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    A. B. Sanchez Spitman
    D. J. A. R. Moes
    H. Gelderblom
    V. O. Dezentje
    J.J. Swen
    H. J. Guchelaar
    European Journal of Clinical Pharmacology, 2017, 73 : 1589 - 1598
  • [3] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    Spitman, A. B. Sanchez
    Moes, D. J. A. R.
    Gelderblom, H.
    Dezentje, V. O.
    Swen, J. J.
    Guchelaar, H. J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1589 - 1598
  • [4] CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients
    Gijsen, Violette M. G. J.
    van Schaik, Ron H. N.
    Elens, Laure
    Soldin, Offie P.
    Soldin, Steven J.
    Koren, Gideon
    de Wildt, Saskia N.
    PHARMACOGENOMICS, 2013, 14 (09) : 1027 - 1036
  • [5] Effect of CYP3A5, CYP3A4, and ABCB1 Genotypes as Determinants of Tacrolimus Dose and Clinical Outcomes After Heart Transplantation
    Diaz-Molina, B.
    Tavira, B.
    Lambert, J. L.
    Bernardo, M. J.
    Alvarez, V.
    Coto, E.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2635 - 2638
  • [6] Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination
    Scheibner, Aileen
    Remmel, Rory
    Schladt, David
    Oetting, William S.
    Guan, Weihua
    Wu, Baolin
    Dorr, Casey
    Israni, Ajay
    Jacobson, Pamala A.
    PHARMACOTHERAPY, 2018, 38 (07): : E46 - E52
  • [7] Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant
    Hannachi, Ibtissem
    Ben Fredj, Nadia
    Chadli, Zohra
    Ben Fadhel, Najah
    Ben Romdhane, Haifa
    Touitou, Yvan
    Boughattas, Naceur A.
    Chaabane, Amel
    Aouam, Karim
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 396
  • [8] Effect of CYP3A5, CYP3A5 and ABCB1 Genotypes in Tacrolimus Dose and Clinical Outcomes after Heart Transplantation
    Tavira, B.
    Diaz-Molina, B.
    Lambert, J. L.
    Bernardo, M. J.
    Moris, C.
    Alvarez, V.
    Lopez-Larrea, C.
    Coto, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S154 - S154
  • [9] Effect of MDR1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, Thomas
    Annaert, Pieter
    Kuypers, Dirk R. J.
    TRANSPLANTATION, 2016, 100 (07) : S167 - S168
  • [10] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    T Vanhove
    P Annaert
    D Lambrechts
    D R J Kuypers
    The Pharmacogenomics Journal, 2017, 17 : 556 - 562
12345